Funder
National Institute for Health and Care Research
National Institutes of Health
National Institute of Allergy and Infectious Diseases
Manchester Biomedical Research Centre
Subject
Neurology (clinical),Neurology,General Medicine
Reference85 articles.
1. Agency, E.M., Tysabri : EPAR - product information https://www.ema.europa.eu/en/documents/product-information/tysabri-epar-product-information_en.pdf. (Accessed 20 Jan 2023 2023).
2. Autologous hematopoietic stem cell transplantation following pulsed cyclophosphamide in a severely disabled patient with malignant multiple sclerosis;Alix;J. Neurol.,2013
3. Aljurf, M., Snowden, J.A., Hayden, P., Orchard, K.H., McGrath, E., 2021. Quality management and accreditation in hematopoietic stem cell transplantation and cellular therapy: the JACIE guide.
4. Aggressive multiple sclerosis (2): treatment;Arrambide;Mult. Scler. J.,2020
5. Predicting secondary progression in relapsing–remitting multiple sclerosis: a Bayesian analysis;Bergamaschi;J. Neurol. Sci.,2001